221 related articles for article (PubMed ID: 36838978)
1. Renoprotective Effects of Tanshinone IIA: A Literature Review.
Chen Z; Feng H; Peng C; Zhang Z; Yuan Q; Gao H; Tang S; Xie C
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838978
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic Extract and Tanshinone IIA Derived from
Zhang XW; Zhou M; An L; Zhang P; Li P; Chen J
Am J Chin Med; 2020; 48(6):1455-1473. PubMed ID: 32933312
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.
Xu S; He L; Ding K; Zhang L; Xu X; Wang S; Qian X
Drug Des Devel Ther; 2020; 14():5773-5782. PubMed ID: 33408464
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
6. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.
Sherawat K; Mehan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1647-1667. PubMed ID: 37010572
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA attenuates renal injury during hypothermic preservation via the MEK/ERK1/2/GSK-3β pathway.
Xu L; Xu Y; Zhu Z; Gu H; Chen C; Chen J
BMC Complement Med Ther; 2021 Oct; 21(1):257. PubMed ID: 34625061
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
12. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress.
Li Y; Fu Y; Sun J; Shen J; Liu F; Ning B; Lu Z; Wei L; Jiang X
J Ethnopharmacol; 2022 Jan; 282():114595. PubMed ID: 34517060
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA Protects Against Folic Acid-Induced Acute Kidney Injury.
Jiang C; Zhu W; Shao Q; Yan X; Jin B; Zhang M; Xu B
Am J Chin Med; 2016; 44(4):737-53. PubMed ID: 27222061
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A.
Wu M; Yang F; Huang D; Ye C
BMC Complement Med Ther; 2022 Apr; 22(1):110. PubMed ID: 35439976
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA Attenuates Contrast-Induced Nephropathy via Nrf2 Activation in Rats.
Liang R; Zhao Q; Jian G; Cheng D; Wang N; Zhang G; Wang F
Cell Physiol Biochem; 2018; 46(6):2616-2623. PubMed ID: 29763899
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA from Salvia miltiorrhiza exerts anti-fibrotic effects on cardiac fibroblasts and rat heart tissues by suppressing the levels of pro-fibrotic factors: The key role of miR-618.
Yan N; Xiao C; Wang X; Xu Z; Yang J
J Food Biochem; 2022 Feb; 46(2):e14078. PubMed ID: 35014054
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis.
An L; Peng LY; Sun NY; Yang YL; Zhang XW; Li B; Liu BL; Li P; Chen J
Antioxid Redox Signal; 2019 May; 30(15):1831-1848. PubMed ID: 30105924
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.
Alam SSM; Samanta A; Uddin F; Ali S; Hoque M
Pharmacol Rep; 2023 Aug; 75(4):907-922. PubMed ID: 37440106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
